IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY
I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE
CIV-2021-404-1828
[2022] NZHC 1272
UNDER Part 18 of the High Court Rules 2016 IN THE MATTER
of Section 174 of the Companies Act 1993
BETWEEN
SOTHILINGIN VIJAYAKUMAR
Plaintiff/Applicant
AND
MANUKAU FAMILY DOCTORS LIMITED
First Defendant/Respondent
SIVA VASANTHAN
Second Defendant/Respondent
Hearing: 3 March 2022, further submissions 17 March 2022 Appearances:
R Harrington for the Plaintiff/Applicant
No appearance for the Frist and Second Defendants/Respondents
Judgment:
1 June 2022
JUDGMENT OF FITZGERALD J
This judgment was delivered by me on 1 June 2022 at 3.00pm, pursuant to Rule 11.5 of the High Court Rules.
Registrar/Deputy Registrar
Date……………
Solicitors: Shieff Angland, Auckland
VIJAYAKUMAR v MANUKAU FAMILY DOCTORS LTD [2022] NZHC 1272 [1 June 2022]
Introduction
[1] This proceeding concerns the management and affairs of the first defendant/respondent, Manukau Family Doctors Limited (the Company). The plaintiff/applicant, Dr Vijayakumar, is a minority shareholder in the Company, holding 120 shares (40 per cent). The other shareholder is the second defendant/respondent, Dr Vasanthan. Dr Vasanthan is the majority shareholder, holding 180 shares (60 per cent). He is also the Company’s sole director.1
[2] The Company is the commercial landlord of premises at Great South Road, Manukau (the Premises). The Premises are the Company’s only significant asset. Dr Vijayakumar, who has resided in Australia since 2006, is dissatisfied with the manner in which Dr Vasanthan is manging the Company, including the terms on which the Premises are being leased to a company associated with Dr Vasanthan.
[3] In an earlier application, Dr Vijayakumar claimed that Dr Vasanthan had breached his duties as a director of the Company, and applied under s 165 of the Companies Act 1993 (the Act) to bring a derivative proceeding against Dr Vasanthan (the Derivative Proceeding). In a judgment delivered on 19 July 2021, Associate Judge Bell declined that application, on the basis that Dr Vijayakumar had a more effective alternative remedy under s 174 of the Act.2
[4] Dr Vijayakumar accordingly filed these proceedings, seeking relief under s 174(2) of the Act. Neither defendant has participated in the proceedings, and accordingly the hearing proceeded by way of formal proof.3
[5]Dr Vijayakumar seeks the following orders pursuant to s 174(2) of the Act:
(a)the Company or Dr Vasanthan acquire his shares in the Company at a price fixed by the Court (pursuant to s 174(2)(a));4
1 Dr Vijayakumar was a director of the Company until August 2012.
2 Vijayakumar v Vasanthan [2021] NZHC 1827 [Derivative Proceeding judgment].
3 Dr Vasanthan did participate in the Derivative Proceeding, representing himself.
4 Valuation evidence relied on by Dr Vijayakumar assesses Dr Vijayakumar’s 40 per cent shareholding in the Company, plus his shareholder current account, at a range of $625,663 to
$709,109 (mid-point of $667,386).
(b)the Company or Dr Vasanthan pay compensation to Dr Vijayakumar for direct losses suffered as a result of Dr Vasanthan’s management of the Company, in a range of $103,395 to $123,121 (pursuant to s 174(2)(b));
(c)the…
Keep reading for free
Create a free CaseChat account to read Vijayakumar v Manukau Family Doctors Limited and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] NZHC 1272
- Decision Date
CaseChat Overview and Summary
The court considered the legal principles governing unfair prejudice claims, the evidence presented, and the appropriate relief to be granted. The court found that the evidence demonstrated that the affairs of the Company have been and are being managed in a way that is oppressive to Dr Vijayakumar as a minority shareholder. The court found that Dr Vasanthan had been content for the Company to receive a lower than market rent from a company associated with him, and that Company funds were being used for the benefit of Dr Vasanthan himself or companies associated with him and his family. The court also found that the claim for consequential losses was not made out on the balance of probabilities.
The court ordered that Dr Vasanthan purchase Dr Vijayakumar’s shares in the Company for a total amount of $667,386, and pay Dr Vijayakumar compensation for direct losses of $79,281. Dr Vijayakumar’s claim for consequential losses of $610,000 was dismissed. Dr Vijayakumar is entitled to costs on a 2B basis for steps taken in this proceeding, plus disbursements.
Final orders were made as follows: Dr Vasanthan purchase Dr Vijayakumar’s shares in the Company for a total amount of $667,386; Dr Vasanthan pay Dr Vijayakumar compensation for direct losses of $79,281; and Dr Vijayakumar’s claim for consequential losses of $610,000 was dismissed. Dr Vijayakumar is entitled to costs on a 2B basis for steps taken in this proceeding, plus disbursements.